WallStreetZenWallStreetZen

NASDAQ: CDLX
Cardlytics Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$1.47-0.03 (-2%)
Updated Apr 21, 2025
CDLX Price
$1.47
Fair Value Price
N/A
Market Cap
$76.57M
52 Week Low
$1.22
52 Week High
$15.89
P/E
-0.38x
P/B
1.09x
P/S
0.65x
PEG
N/A
Dividend Yield
N/A
Revenue
$278.30M
Earnings
-$189.30M
Gross Margin
43.4%
Operating Margin
-66.03%
Profit Margin
-68%
Debt to Equity
4.61
Operating Cash Flow
-$9M
Beta
2.28
Next Earnings
Apr 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CDLX Overview

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CDLX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

F
Value
C
Growth
F
Momentum
C
Sentiment
C
Safety
C
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Advertising Agency

Industry Rating
A
CDLX
Ranked#25 of 29

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Nexxen International (NEXN)
$8.92A
Townsquare Media (TSQ)
$6.74A
Deluxe (DLX)
$14.22A
View Top Advertising Agency Stocks

Be the first to know about important CDLX news, forecast changes, insider trades & much more!

CDLX News

Overview

Due Diligence Score

–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CDLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CDLX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CDLX is good value based on its book value relative to its share price (1.09x), compared to the US Advertising Agencies industry average (2.44x)
P/B vs Industry Valuation
CDLX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CDLX due diligence checks available for Premium users.

Valuation

CDLX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.38x
Industry
14.87x
Market
27.14x

CDLX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.09x
Industry
2.44x
CDLX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CDLX's financial health

Profit margin

Revenue
$74.0M
Net Income
-$15.6M
Profit Margin
-21.1%
CDLX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CDLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$392.7M
Liabilities
$322.7M
Debt to equity
4.61
CDLX's short-term assets ($177.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDLX's short-term assets ($177.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDLX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CDLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.0M
Investing
-$4.1M
Financing
-$202.0k
CDLX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CDLX vs Advertising Agency Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CDLXC$76.57M-2.00%-0.38x1.09x
MCHX–$61.86M-3.74%-12.86x1.90x
INUV–$53.98M-4.06%-9.45x4.01x
TZUPC$45.81M-3.38%-9.72x9.61x
TSQA$108.64M-2.74%-8.32x-3.41x
View Top Advertising Agency Stocks

Cardlytics Stock FAQ

What is Cardlytics's quote symbol?

(NASDAQ: CDLX) Cardlytics trades on the NASDAQ under the ticker symbol CDLX. Cardlytics stock quotes can also be displayed as NASDAQ: CDLX.

If you're new to stock investing, here's how to buy Cardlytics stock.

What is the 52 week high and low for Cardlytics (NASDAQ: CDLX)?

(NASDAQ: CDLX) Cardlytics's 52-week high was $15.89, and its 52-week low was $1.22. It is currently -90.75% from its 52-week high and 20.49% from its 52-week low.

How much is Cardlytics stock worth today?

(NASDAQ: CDLX) Cardlytics currently has 52,085,224 outstanding shares. With Cardlytics stock trading at $1.47 per share, the total value of Cardlytics stock (market capitalization) is $76.57M.

Cardlytics stock was originally listed at a price of $13.37 in Feb 9, 2018. If you had invested in Cardlytics stock at $13.37, your return over the last 7 years would have been -89.01%, for an annualized return of -27.05% (not including any dividends or dividend reinvestments).

How much is Cardlytics's stock price per share?

(NASDAQ: CDLX) Cardlytics stock price per share is $1.47 today (as of Apr 21, 2025).

What is Cardlytics's Market Cap?

(NASDAQ: CDLX) Cardlytics's market cap is $76.57M, as of Apr 23, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cardlytics's market cap is calculated by multiplying CDLX's current stock price of $1.47 by CDLX's total outstanding shares of 52,085,224.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.